Latest results from the PUP-GCP clinical trial: a low inhibitor rate in previously untreated patients with severe hemophilia A treated with octanate

被引：0

作者：

Klukowska, A. ^{[1
]}

Jansen, M. ^{[2
]}

Komrska, V. ^{[3
]}

Laguna, P. ^{[1
]}

Vdovin, V. ^{[4
]}

Knaub, S. ^{[5
]}

机构：

[1] Med Univ Warsaw, Dept Paediat Haematol & Oncol, Warsaw, Poland

[2] Octapharma Prod Gesell mbH, Vienna, Austria

[3] Univ Hosp Motol, Dept Pediat Haematol & Oncol, Prague, Czech Republic

[4] Izmaylovo Childrens Hosp, Haematol Ctr, Moscow, Russia

[5] OCTAPHARMA AG, Clin R&D Dept, Lachen, Switzerland

来源：

HAEMOPHILIA | 2014年 / 20卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：19 / 20

页数：2

共 50 条

[1] Latest results from The PUP-GCP clinical trial: A low inhibitor rate in previously untreated patients with severe hemophilia A treated with Octanate
Klukowska, Anna
Knaub, Sigurd
Komrska, Vladimir
Laguna, Pawel
Vdovin, Vladimir
Jansen, Martina
HAEMOPHILIA, 2014, 20 : 17 - 17
[2] Latest results from the PUP-GCP clinical trial: a low inhibitor rate in previously untreated patients with severe hemophilia A treated with octanate
Klukowska, A.
Jansen, M.
Komrska, V
Laguna, P.
Vdovin, V.
Knaub, S.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 : 38 - 38
[3] Latest Results From The PUP-GCP Clinical Trial: A Low Inhibitor Rate In Previously Untreated Patients With Severe Hemophilia A Treated With Octanate
Klukowska, Anna
Jansen, Martina
Komrska, Vladimir
Laguna, Pawel
Vdovin, Vladimir
Knaub, Sigurd
BLOOD, 2013, 122 (21)
[4] The PUP-GCP Clinical Trial: A Low Inhibitor Rate in Previously Untreated Patients with Severe Hemophilia a Treated with Octanate
Knaub, Sigurd
Klukowska, Anna
Komrska, Vladimir
Laguna, Pawel
Vladimir, Vdovin
Jansen, Martina
BLOOD, 2014, 124 (21)
[5] Low inhibitor incidence in previously untreated patients with hemophilia A treated with octanate®'s latest interim results from a PUP-GCP clinical trial
Klukowska, A.
Komrska, V.
Jansen, M.
Laguna, P.
HAEMOPHILIA, 2012, 18 : 23 - 23
[6] Low inhibitor incidence in previously untreated patients with severe haemophilia A treated with octanate - Update from the PUP-GCP clinical trial
Jansen, M.
Klukowska, A.
Komrska, V
Laguna, P.
Vdovin, V.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 797 - 797
[7] Low inhibitor incidence in previously untreated patients with severe haemophilia a treated with OCTANATE® - update from the PUP-GCP clinical trial
Jansen, M.
Klukowska, A.
Komrska, V.
Laguna, P.
HAEMOPHILIA, 2013, 19 : 68 - 69
[8] Low inhibitor incidence in previously untreated patients with severe haemophilia A treated with Octanate® - Update from the PUP-GCP clinical trial
Jansen, M.
Klukowska, A.
Komrska, V.
Laguna, P.
Schwartz, B.
HAEMOPHILIA, 2013, 19 (03) : 467 - 467
[9] LATEST RESULTS FROM THE PUP-GCP CLINICAL TRIAL: A LOW INHIBITOR RATE IN PREVIOUSLY UNTREATED PATIENTS WITH SEVERE HEMOPHILIA A TREATED WITH A PLASMA-DERIVED FVIII CONCENTRATE
Klukowska, Anna
Jansen, Martina
Komrska, Vladimir
Laguna, Pawel
Vdovin, Vladimir
Knaub, Sigurd
AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (06) : E40 - E41
[10] Results from the PUP-GCP clinical trial: low inhibitor rate in previously untreated patients with severe haemophilia a treated with a plasma derived FVIII concentrate
Klukowska, A.
Knaub, S.
Komrska, V
Laguna, P.
Vdovin, V.
Jansen, M.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 355 - 356

← 1 2 3 4 5 →